FDA Grants Approval for High Dose SPINRAZA to Benefit SMA Patients Cure SMA celebrates the FDA's approval of Biogen's High Dose SPINRAZA regimen, providing hope and improved care for individuals living with SMA.

FDA Grants Approval for High Dose SPINRAZA to Benefit SMA Patients #USA #SMA #Schaumburg #Cure_SMA #SPINRAZA

Federal Legislation Offers New Hope for Families Affected by SMA Through Enhanced Research and Access Recent federal legislation has been signed into law, providing new research opportunities and improved access to care for families living with spinal muscular atrophy (SMA).

Federal Legislation Offers New Hope for Families Affected by SMA Through Enhanced Research and Access #United_States #Washington #Cure_SMA #spinal_muscular_atrophy #SMA_community

Cure SMA Celebrates FDA Approval of Itvisma™ for SMA, Enhancing Treatment Access and Support Cure SMA's recent FDA approval of Itvisma™ marks a critical milestone for individuals with spinal muscular atrophy, ensuring wider treatment access and support.

Cure SMA Celebrates FDA Approval of Itvisma™ for SMA, Enhancing Treatment Access and Support #United_States #Schaumburg #Cure_SMA #Itvisma™ #spinal_muscular_atrophy